nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—CYP1A2—Dacarbazine—pancreatic cancer	0.0965	0.327	CbGbCtD
Tizanidine—CYP1A2—Tamoxifen—pancreatic cancer	0.0768	0.26	CbGbCtD
Tizanidine—CYP1A2—Erlotinib—pancreatic cancer	0.0653	0.221	CbGbCtD
Tizanidine—CYP1A2—Fluorouracil—pancreatic cancer	0.0566	0.192	CbGbCtD
Tizanidine—NISCH—Paclitaxel—Docetaxel—pancreatic cancer	0.0127	1	CbGdCrCtD
Tizanidine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000383	0.000624	CcSEcCtD
Tizanidine—Bronchitis—Epirubicin—pancreatic cancer	0.000383	0.000624	CcSEcCtD
Tizanidine—Anaemia—Docetaxel—pancreatic cancer	0.00038	0.000619	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000376	0.000612	CcSEcCtD
Tizanidine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000376	0.000612	CcSEcCtD
Tizanidine—Vomiting—Sunitinib—pancreatic cancer	0.000375	0.000611	CcSEcCtD
Tizanidine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000374	0.000609	CcSEcCtD
Tizanidine—Rash—Sunitinib—pancreatic cancer	0.000372	0.000606	CcSEcCtD
Tizanidine—Dermatitis—Sunitinib—pancreatic cancer	0.000371	0.000605	CcSEcCtD
Tizanidine—Urticaria—Fluorouracil—pancreatic cancer	0.000369	0.000602	CcSEcCtD
Tizanidine—Syncope—Docetaxel—pancreatic cancer	0.000369	0.000601	CcSEcCtD
Tizanidine—Asthma—Doxorubicin—pancreatic cancer	0.000368	0.0006	CcSEcCtD
Tizanidine—Dysphagia—Doxorubicin—pancreatic cancer	0.000368	0.0006	CcSEcCtD
Tizanidine—Influenza—Doxorubicin—pancreatic cancer	0.000368	0.0006	CcSEcCtD
Tizanidine—Leukopenia—Docetaxel—pancreatic cancer	0.000368	0.0006	CcSEcCtD
Tizanidine—Pollakiuria—Epirubicin—pancreatic cancer	0.000368	0.000599	CcSEcCtD
Tizanidine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000368	0.000599	CcSEcCtD
Tizanidine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000362	0.000589	CcSEcCtD
Tizanidine—Weight decreased—Epirubicin—pancreatic cancer	0.00036	0.000587	CcSEcCtD
Tizanidine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000359	0.000585	CcSEcCtD
Tizanidine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000359	0.000585	CcSEcCtD
Tizanidine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000358	0.000583	CcSEcCtD
Tizanidine—Pneumonia—Epirubicin—pancreatic cancer	0.000357	0.000582	CcSEcCtD
Tizanidine—Convulsion—Docetaxel—pancreatic cancer	0.000356	0.000581	CcSEcCtD
Tizanidine—Hypertension—Docetaxel—pancreatic cancer	0.000355	0.000579	CcSEcCtD
Tizanidine—Drowsiness—Epirubicin—pancreatic cancer	0.000355	0.000578	CcSEcCtD
Tizanidine—Bronchitis—Doxorubicin—pancreatic cancer	0.000354	0.000577	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000352	0.000573	CcSEcCtD
Tizanidine—Arthralgia—Docetaxel—pancreatic cancer	0.00035	0.00057	CcSEcCtD
Tizanidine—Nausea—Sunitinib—pancreatic cancer	0.00035	0.00057	CcSEcCtD
Tizanidine—Renal failure—Epirubicin—pancreatic cancer	0.000349	0.000569	CcSEcCtD
Tizanidine—Asthenia—Irinotecan—pancreatic cancer	0.000348	0.000568	CcSEcCtD
Tizanidine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000348	0.000567	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000348	0.000567	CcSEcCtD
Tizanidine—Jaundice—Epirubicin—pancreatic cancer	0.000346	0.000564	CcSEcCtD
Tizanidine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000345	0.000562	CcSEcCtD
Tizanidine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000343	0.000558	CcSEcCtD
Tizanidine—Dry mouth—Docetaxel—pancreatic cancer	0.000342	0.000558	CcSEcCtD
Tizanidine—Sweating—Epirubicin—pancreatic cancer	0.00034	0.000554	CcSEcCtD
Tizanidine—Pollakiuria—Doxorubicin—pancreatic cancer	0.00034	0.000554	CcSEcCtD
Tizanidine—Asthenia—Gemcitabine—pancreatic cancer	0.000339	0.000553	CcSEcCtD
Tizanidine—Haematuria—Epirubicin—pancreatic cancer	0.000338	0.000551	CcSEcCtD
Tizanidine—Confusional state—Docetaxel—pancreatic cancer	0.000338	0.000551	CcSEcCtD
Tizanidine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000336	0.000547	CcSEcCtD
Tizanidine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000336	0.000547	CcSEcCtD
Tizanidine—Oedema—Docetaxel—pancreatic cancer	0.000336	0.000547	CcSEcCtD
Tizanidine—Pruritus—Gemcitabine—pancreatic cancer	0.000335	0.000545	CcSEcCtD
Tizanidine—Infection—Docetaxel—pancreatic cancer	0.000334	0.000543	CcSEcCtD
Tizanidine—Weight decreased—Doxorubicin—pancreatic cancer	0.000333	0.000543	CcSEcCtD
Tizanidine—Sinusitis—Epirubicin—pancreatic cancer	0.000333	0.000543	CcSEcCtD
Tizanidine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000332	0.000541	CcSEcCtD
Tizanidine—Diarrhoea—Irinotecan—pancreatic cancer	0.000332	0.000541	CcSEcCtD
Tizanidine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000331	0.00054	CcSEcCtD
Tizanidine—Pneumonia—Doxorubicin—pancreatic cancer	0.00033	0.000538	CcSEcCtD
Tizanidine—Shock—Docetaxel—pancreatic cancer	0.00033	0.000538	CcSEcCtD
Tizanidine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000329	0.000536	CcSEcCtD
Tizanidine—Pruritus—Fluorouracil—pancreatic cancer	0.000329	0.000536	CcSEcCtD
Tizanidine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000329	0.000535	CcSEcCtD
Tizanidine—Drowsiness—Doxorubicin—pancreatic cancer	0.000328	0.000535	CcSEcCtD
Tizanidine—Tachycardia—Docetaxel—pancreatic cancer	0.000328	0.000534	CcSEcCtD
Tizanidine—Skin disorder—Docetaxel—pancreatic cancer	0.000326	0.000531	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000326	0.000531	CcSEcCtD
Tizanidine—Bradycardia—Epirubicin—pancreatic cancer	0.000324	0.000529	CcSEcCtD
Tizanidine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000324	0.000527	CcSEcCtD
Tizanidine—Renal failure—Doxorubicin—pancreatic cancer	0.000323	0.000526	CcSEcCtD
Tizanidine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000322	0.000525	CcSEcCtD
Tizanidine—Dizziness—Irinotecan—pancreatic cancer	0.000321	0.000523	CcSEcCtD
Tizanidine—Haemoglobin—Epirubicin—pancreatic cancer	0.00032	0.000522	CcSEcCtD
Tizanidine—Jaundice—Doxorubicin—pancreatic cancer	0.00032	0.000522	CcSEcCtD
Tizanidine—Rhinitis—Epirubicin—pancreatic cancer	0.00032	0.000521	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000319	0.00052	CcSEcCtD
Tizanidine—Hepatitis—Epirubicin—pancreatic cancer	0.000319	0.000519	CcSEcCtD
Tizanidine—Haemorrhage—Epirubicin—pancreatic cancer	0.000319	0.000519	CcSEcCtD
Tizanidine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000318	0.000518	CcSEcCtD
Tizanidine—Pharyngitis—Epirubicin—pancreatic cancer	0.000316	0.000515	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—pancreatic cancer	0.000315	0.000513	CcSEcCtD
Tizanidine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000315	0.000513	CcSEcCtD
Tizanidine—Hypotension—Docetaxel—pancreatic cancer	0.000314	0.000511	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—pancreatic cancer	0.000313	0.00051	CcSEcCtD
Tizanidine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000313	0.00051	CcSEcCtD
Tizanidine—Urethral disorder—Epirubicin—pancreatic cancer	0.000312	0.000509	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000311	0.000506	CcSEcCtD
Tizanidine—Vomiting—Irinotecan—pancreatic cancer	0.000309	0.000503	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—pancreatic cancer	0.000308	0.000502	CcSEcCtD
Tizanidine—Dizziness—Fluorouracil—pancreatic cancer	0.000308	0.000501	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000307	0.000499	CcSEcCtD
Tizanidine—Rash—Irinotecan—pancreatic cancer	0.000306	0.000499	CcSEcCtD
Tizanidine—Dermatitis—Irinotecan—pancreatic cancer	0.000306	0.000498	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000306	0.000498	CcSEcCtD
Tizanidine—Paraesthesia—Docetaxel—pancreatic cancer	0.000301	0.000491	CcSEcCtD
Tizanidine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000301	0.000491	CcSEcCtD
Tizanidine—Vomiting—Gemcitabine—pancreatic cancer	0.000301	0.00049	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—pancreatic cancer	0.0003	0.000489	CcSEcCtD
Tizanidine—Dyspnoea—Docetaxel—pancreatic cancer	0.000299	0.000488	CcSEcCtD
Tizanidine—Somnolence—Docetaxel—pancreatic cancer	0.000298	0.000486	CcSEcCtD
Tizanidine—Rash—Gemcitabine—pancreatic cancer	0.000298	0.000486	CcSEcCtD
Tizanidine—Dermatitis—Gemcitabine—pancreatic cancer	0.000298	0.000485	CcSEcCtD
Tizanidine—Tinnitus—Epirubicin—pancreatic cancer	0.000297	0.000484	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—pancreatic cancer	0.000296	0.000483	CcSEcCtD
Tizanidine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000296	0.000482	CcSEcCtD
Tizanidine—Vomiting—Fluorouracil—pancreatic cancer	0.000296	0.000482	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—pancreatic cancer	0.000296	0.000482	CcSEcCtD
Tizanidine—Dyspepsia—Docetaxel—pancreatic cancer	0.000295	0.000481	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—pancreatic cancer	0.000295	0.00048	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—pancreatic cancer	0.000295	0.00048	CcSEcCtD
Tizanidine—Rash—Fluorouracil—pancreatic cancer	0.000293	0.000478	CcSEcCtD
Tizanidine—Dermatitis—Fluorouracil—pancreatic cancer	0.000293	0.000477	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000293	0.000477	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000291	0.000474	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00029	0.000472	CcSEcCtD
Tizanidine—Fatigue—Docetaxel—pancreatic cancer	0.000289	0.000472	CcSEcCtD
Tizanidine—Angiopathy—Epirubicin—pancreatic cancer	0.000289	0.000471	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000289	0.000471	CcSEcCtD
Tizanidine—Nausea—Irinotecan—pancreatic cancer	0.000288	0.00047	CcSEcCtD
Tizanidine—Immune system disorder—Epirubicin—pancreatic cancer	0.000288	0.000469	CcSEcCtD
Tizanidine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000287	0.000468	CcSEcCtD
Tizanidine—Constipation—Docetaxel—pancreatic cancer	0.000287	0.000468	CcSEcCtD
Tizanidine—Arrhythmia—Epirubicin—pancreatic cancer	0.000285	0.000464	CcSEcCtD
Tizanidine—Alopecia—Epirubicin—pancreatic cancer	0.000282	0.000459	CcSEcCtD
Tizanidine—Nausea—Gemcitabine—pancreatic cancer	0.000281	0.000458	CcSEcCtD
Tizanidine—Mental disorder—Epirubicin—pancreatic cancer	0.000279	0.000455	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000279	0.000454	CcSEcCtD
Tizanidine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000277	0.000451	CcSEcCtD
Tizanidine—Nausea—Fluorouracil—pancreatic cancer	0.000276	0.00045	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—pancreatic cancer	0.000275	0.000448	CcSEcCtD
Tizanidine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000275	0.000447	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000274	0.000446	CcSEcCtD
Tizanidine—Flatulence—Epirubicin—pancreatic cancer	0.000273	0.000445	CcSEcCtD
Tizanidine—Tension—Epirubicin—pancreatic cancer	0.000272	0.000444	CcSEcCtD
Tizanidine—Nervousness—Epirubicin—pancreatic cancer	0.000269	0.000439	CcSEcCtD
Tizanidine—Back pain—Epirubicin—pancreatic cancer	0.000268	0.000437	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—pancreatic cancer	0.000268	0.000436	CcSEcCtD
Tizanidine—Muscle spasms—Epirubicin—pancreatic cancer	0.000267	0.000435	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000266	0.000434	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000266	0.000433	CcSEcCtD
Tizanidine—Abdominal pain—Docetaxel—pancreatic cancer	0.000265	0.000432	CcSEcCtD
Tizanidine—Body temperature increased—Docetaxel—pancreatic cancer	0.000265	0.000432	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000263	0.000429	CcSEcCtD
Tizanidine—Vision blurred—Epirubicin—pancreatic cancer	0.000261	0.000426	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—pancreatic cancer	0.000261	0.000425	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—pancreatic cancer	0.000258	0.000421	CcSEcCtD
Tizanidine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000257	0.000419	CcSEcCtD
Tizanidine—Anaemia—Epirubicin—pancreatic cancer	0.000256	0.000418	CcSEcCtD
Tizanidine—Agitation—Epirubicin—pancreatic cancer	0.000255	0.000415	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—pancreatic cancer	0.000253	0.000412	CcSEcCtD
Tizanidine—Tension—Doxorubicin—pancreatic cancer	0.000252	0.00041	CcSEcCtD
Tizanidine—Malaise—Epirubicin—pancreatic cancer	0.00025	0.000408	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—pancreatic cancer	0.000249	0.000406	CcSEcCtD
Tizanidine—Vertigo—Epirubicin—pancreatic cancer	0.000249	0.000406	CcSEcCtD
Tizanidine—Syncope—Epirubicin—pancreatic cancer	0.000249	0.000405	CcSEcCtD
Tizanidine—Leukopenia—Epirubicin—pancreatic cancer	0.000248	0.000405	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—pancreatic cancer	0.000248	0.000405	CcSEcCtD
Tizanidine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000247	0.000403	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000247	0.000402	CcSEcCtD
Tizanidine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000244	0.000397	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—pancreatic cancer	0.000242	0.000394	CcSEcCtD
Tizanidine—Asthenia—Docetaxel—pancreatic cancer	0.000241	0.000392	CcSEcCtD
Tizanidine—Convulsion—Epirubicin—pancreatic cancer	0.00024	0.000392	CcSEcCtD
Tizanidine—Hypertension—Epirubicin—pancreatic cancer	0.00024	0.00039	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000238	0.000388	CcSEcCtD
Tizanidine—Pruritus—Docetaxel—pancreatic cancer	0.000238	0.000387	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—pancreatic cancer	0.000237	0.000387	CcSEcCtD
Tizanidine—Arthralgia—Epirubicin—pancreatic cancer	0.000236	0.000385	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—pancreatic cancer	0.000236	0.000384	CcSEcCtD
Tizanidine—Anxiety—Epirubicin—pancreatic cancer	0.000235	0.000383	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000235	0.000382	CcSEcCtD
Tizanidine—Discomfort—Epirubicin—pancreatic cancer	0.000233	0.00038	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—pancreatic cancer	0.000231	0.000377	CcSEcCtD
Tizanidine—Dry mouth—Epirubicin—pancreatic cancer	0.000231	0.000376	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—pancreatic cancer	0.000231	0.000376	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—pancreatic cancer	0.00023	0.000375	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—pancreatic cancer	0.00023	0.000374	CcSEcCtD
Tizanidine—Diarrhoea—Docetaxel—pancreatic cancer	0.00023	0.000374	CcSEcCtD
Tizanidine—Confusional state—Epirubicin—pancreatic cancer	0.000228	0.000372	CcSEcCtD
Tizanidine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000226	0.000369	CcSEcCtD
Tizanidine—Oedema—Epirubicin—pancreatic cancer	0.000226	0.000369	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000226	0.000368	CcSEcCtD
Tizanidine—Infection—Epirubicin—pancreatic cancer	0.000225	0.000366	CcSEcCtD
Tizanidine—Shock—Epirubicin—pancreatic cancer	0.000223	0.000363	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—pancreatic cancer	0.000222	0.000362	CcSEcCtD
Tizanidine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000222	0.000362	CcSEcCtD
Tizanidine—Dizziness—Docetaxel—pancreatic cancer	0.000222	0.000362	CcSEcCtD
Tizanidine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000222	0.000361	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—pancreatic cancer	0.000222	0.000361	CcSEcCtD
Tizanidine—Tachycardia—Epirubicin—pancreatic cancer	0.000221	0.00036	CcSEcCtD
Tizanidine—Skin disorder—Epirubicin—pancreatic cancer	0.00022	0.000358	CcSEcCtD
Tizanidine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000219	0.000357	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—pancreatic cancer	0.000219	0.000356	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—pancreatic cancer	0.000218	0.000355	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000217	0.000354	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—pancreatic cancer	0.000216	0.000352	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—pancreatic cancer	0.000214	0.000348	CcSEcCtD
Tizanidine—Vomiting—Docetaxel—pancreatic cancer	0.000213	0.000348	CcSEcCtD
Tizanidine—Rash—Docetaxel—pancreatic cancer	0.000212	0.000345	CcSEcCtD
Tizanidine—Hypotension—Epirubicin—pancreatic cancer	0.000212	0.000345	CcSEcCtD
Tizanidine—Dermatitis—Docetaxel—pancreatic cancer	0.000211	0.000345	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—pancreatic cancer	0.000211	0.000344	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00021	0.000341	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—pancreatic cancer	0.00021	0.000341	CcSEcCtD
Tizanidine—Infection—Doxorubicin—pancreatic cancer	0.000208	0.000339	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000206	0.000336	CcSEcCtD
Tizanidine—Shock—Doxorubicin—pancreatic cancer	0.000206	0.000336	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000205	0.000335	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000205	0.000334	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—pancreatic cancer	0.000204	0.000333	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—pancreatic cancer	0.000203	0.000332	CcSEcCtD
Tizanidine—Paraesthesia—Epirubicin—pancreatic cancer	0.000203	0.000331	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000203	0.00033	CcSEcCtD
Tizanidine—Dyspnoea—Epirubicin—pancreatic cancer	0.000202	0.000329	CcSEcCtD
Tizanidine—Somnolence—Epirubicin—pancreatic cancer	0.000201	0.000328	CcSEcCtD
Tizanidine—Nausea—Docetaxel—pancreatic cancer	0.000199	0.000325	CcSEcCtD
Tizanidine—Dyspepsia—Epirubicin—pancreatic cancer	0.000199	0.000325	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—pancreatic cancer	0.000196	0.000319	CcSEcCtD
Tizanidine—Fatigue—Epirubicin—pancreatic cancer	0.000195	0.000318	CcSEcCtD
Tizanidine—Constipation—Epirubicin—pancreatic cancer	0.000194	0.000315	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000191	0.000311	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000188	0.000306	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000187	0.000304	CcSEcCtD
Tizanidine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000187	0.000304	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—pancreatic cancer	0.000186	0.000303	CcSEcCtD
Tizanidine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000185	0.000302	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000184	0.0003	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—pancreatic cancer	0.000181	0.000294	CcSEcCtD
Tizanidine—Urticaria—Epirubicin—pancreatic cancer	0.00018	0.000293	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—pancreatic cancer	0.000179	0.000292	CcSEcCtD
Tizanidine—Body temperature increased—Epirubicin—pancreatic cancer	0.000179	0.000292	CcSEcCtD
Tizanidine—Abdominal pain—Epirubicin—pancreatic cancer	0.000179	0.000292	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000173	0.000281	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000171	0.000279	CcSEcCtD
Tizanidine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000167	0.000272	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—pancreatic cancer	0.000166	0.000271	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000166	0.00027	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000166	0.00027	CcSEcCtD
Tizanidine—Asthenia—Epirubicin—pancreatic cancer	0.000162	0.000265	CcSEcCtD
Tizanidine—Pruritus—Epirubicin—pancreatic cancer	0.00016	0.000261	CcSEcCtD
Tizanidine—Diarrhoea—Epirubicin—pancreatic cancer	0.000155	0.000252	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000154	0.000251	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—pancreatic cancer	0.00015	0.000245	CcSEcCtD
Tizanidine—Dizziness—Epirubicin—pancreatic cancer	0.00015	0.000244	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—pancreatic cancer	0.000148	0.000241	CcSEcCtD
Tizanidine—Vomiting—Epirubicin—pancreatic cancer	0.000144	0.000235	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000143	0.000234	CcSEcCtD
Tizanidine—Rash—Epirubicin—pancreatic cancer	0.000143	0.000233	CcSEcCtD
Tizanidine—Dermatitis—Epirubicin—pancreatic cancer	0.000143	0.000232	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—pancreatic cancer	0.000139	0.000226	CcSEcCtD
Tizanidine—Nausea—Epirubicin—pancreatic cancer	0.000134	0.000219	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—pancreatic cancer	0.000133	0.000217	CcSEcCtD
Tizanidine—Rash—Doxorubicin—pancreatic cancer	0.000132	0.000215	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—pancreatic cancer	0.000132	0.000215	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—pancreatic cancer	0.000124	0.000203	CcSEcCtD
Tizanidine—ADRA2B—Signaling Pathways—JAG1—pancreatic cancer	4.45e-05	0.000569	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CNR2—pancreatic cancer	4.44e-05	0.000567	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GLP1R—pancreatic cancer	4.44e-05	0.000567	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—CXCL8—pancreatic cancer	4.44e-05	0.000567	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH3—pancreatic cancer	4.43e-05	0.000566	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCKAR—pancreatic cancer	4.37e-05	0.000558	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—SRC—pancreatic cancer	4.36e-05	0.000557	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—STK11—pancreatic cancer	4.26e-05	0.000544	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SST—pancreatic cancer	4.25e-05	0.000543	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—VEGFA—pancreatic cancer	4.25e-05	0.000542	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JAG2—pancreatic cancer	4.24e-05	0.000541	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CNR1—pancreatic cancer	4.2e-05	0.000536	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—NRAS—pancreatic cancer	4.2e-05	0.000536	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.19e-05	0.000535	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MEN1—pancreatic cancer	4.17e-05	0.000533	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ARG2—pancreatic cancer	4.16e-05	0.000531	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—JAG1—pancreatic cancer	4.16e-05	0.000531	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH3—pancreatic cancer	4.14e-05	0.000529	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CB—pancreatic cancer	4.13e-05	0.000527	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CG—pancreatic cancer	4.08e-05	0.000521	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—SRC—pancreatic cancer	4.07e-05	0.00052	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GCG—pancreatic cancer	4.06e-05	0.000518	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.99e-05	0.000509	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SHH—pancreatic cancer	3.98e-05	0.000509	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—VEGFA—pancreatic cancer	3.97e-05	0.000507	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH4—pancreatic cancer	3.96e-05	0.000505	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.95e-05	0.000504	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IAPP—pancreatic cancer	3.93e-05	0.000502	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CNR1—pancreatic cancer	3.92e-05	0.000501	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—NRAS—pancreatic cancer	3.92e-05	0.000501	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TGFB1—pancreatic cancer	3.9e-05	0.000498	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AGTR1—pancreatic cancer	3.87e-05	0.000494	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CD44—pancreatic cancer	3.84e-05	0.00049	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STK11—pancreatic cancer	3.81e-05	0.000487	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CG—pancreatic cancer	3.81e-05	0.000486	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GCG—pancreatic cancer	3.79e-05	0.000484	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTHLH—pancreatic cancer	3.77e-05	0.000482	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTCH1—pancreatic cancer	3.77e-05	0.000482	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.69e-05	0.000471	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GCG—pancreatic cancer	3.68e-05	0.00047	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—TYMS—pancreatic cancer	3.66e-05	0.000468	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TGFB1—pancreatic cancer	3.64e-05	0.000465	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TYMP—pancreatic cancer	3.64e-05	0.000464	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AGTR1—pancreatic cancer	3.61e-05	0.000462	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—KRAS—pancreatic cancer	3.61e-05	0.000461	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CD—pancreatic cancer	3.58e-05	0.000458	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STK11—pancreatic cancer	3.56e-05	0.000455	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—STK11—pancreatic cancer	3.46e-05	0.000442	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SST—pancreatic cancer	3.45e-05	0.000441	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.44e-05	0.000439	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.41e-05	0.000435	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JAG1—pancreatic cancer	3.38e-05	0.000432	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—KRAS—pancreatic cancer	3.37e-05	0.000431	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH3—pancreatic cancer	3.36e-05	0.00043	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CD—pancreatic cancer	3.35e-05	0.000427	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SMAD4—pancreatic cancer	3.34e-05	0.000427	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—PIK3CA—pancreatic cancer	3.32e-05	0.000424	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—SRC—pancreatic cancer	3.31e-05	0.000423	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—CXCL8—pancreatic cancer	3.3e-05	0.000422	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HES1—pancreatic cancer	3.26e-05	0.000417	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—pancreatic cancer	3.22e-05	0.000412	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.21e-05	0.00041	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TP53—pancreatic cancer	3.21e-05	0.00041	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CNR1—pancreatic cancer	3.19e-05	0.000407	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—NRAS—pancreatic cancer	3.18e-05	0.000407	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CB—pancreatic cancer	3.12e-05	0.000399	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SMAD4—pancreatic cancer	3.12e-05	0.000398	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—PIK3CA—pancreatic cancer	3.1e-05	0.000396	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	3.09e-05	0.000395	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—CXCL8—pancreatic cancer	3.09e-05	0.000394	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GCG—pancreatic cancer	3.08e-05	0.000393	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—HRAS—pancreatic cancer	3.07e-05	0.000392	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HES1—pancreatic cancer	3.05e-05	0.000389	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—CXCL8—pancreatic cancer	3e-05	0.000383	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3e-05	0.000383	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TP53—pancreatic cancer	3e-05	0.000383	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.99e-05	0.000382	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—APOE—pancreatic cancer	2.98e-05	0.000381	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—TYMS—pancreatic cancer	2.98e-05	0.00038	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB1—pancreatic cancer	2.96e-05	0.000378	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AGTR1—pancreatic cancer	2.94e-05	0.000375	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	2.93e-05	0.000374	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CB—pancreatic cancer	2.92e-05	0.000373	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	2.89e-05	0.00037	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—DPYD—pancreatic cancer	2.88e-05	0.000368	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—HRAS—pancreatic cancer	2.87e-05	0.000366	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TERT—pancreatic cancer	2.86e-05	0.000365	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL8—pancreatic cancer	2.8e-05	0.000358	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—KRAS—pancreatic cancer	2.74e-05	0.00035	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	2.74e-05	0.000349	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HIF1A—pancreatic cancer	2.73e-05	0.000349	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TSC2—pancreatic cancer	2.73e-05	0.000348	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.72e-05	0.000347	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—pancreatic cancer	2.71e-05	0.000346	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.71e-05	0.000346	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CG—pancreatic cancer	2.69e-05	0.000344	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TERT—pancreatic cancer	2.67e-05	0.000341	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOE—pancreatic cancer	2.67e-05	0.000341	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KDR—pancreatic cancer	2.61e-05	0.000334	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.61e-05	0.000334	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.61e-05	0.000333	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—pancreatic cancer	2.6e-05	0.000332	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HIF1A—pancreatic cancer	2.55e-05	0.000326	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TSC2—pancreatic cancer	2.55e-05	0.000325	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	2.53e-05	0.000324	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—pancreatic cancer	2.53e-05	0.000323	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	2.52e-05	0.000321	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	2.51e-05	0.00032	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOE—pancreatic cancer	2.49e-05	0.000318	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NFKBIA—pancreatic cancer	2.49e-05	0.000318	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	2.47e-05	0.000316	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NOTCH1—pancreatic cancer	2.46e-05	0.000314	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KDR—pancreatic cancer	2.44e-05	0.000312	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TP53—pancreatic cancer	2.43e-05	0.000311	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOE—pancreatic cancer	2.42e-05	0.000309	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CG—pancreatic cancer	2.41e-05	0.000308	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—NRAS—pancreatic cancer	2.41e-05	0.000308	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.38e-05	0.000304	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGF—pancreatic cancer	2.38e-05	0.000304	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.37e-05	0.000303	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CD—pancreatic cancer	2.36e-05	0.000302	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—HRAS—pancreatic cancer	2.33e-05	0.000297	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NFKBIA—pancreatic cancer	2.32e-05	0.000297	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NOTCH1—pancreatic cancer	2.3e-05	0.000294	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	2.28e-05	0.000291	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CG—pancreatic cancer	2.25e-05	0.000287	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—NRAS—pancreatic cancer	2.25e-05	0.000287	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGF—pancreatic cancer	2.22e-05	0.000284	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—pancreatic cancer	2.19e-05	0.00028	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	2.18e-05	0.000279	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	2.17e-05	0.000277	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CD44—pancreatic cancer	2.12e-05	0.000271	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CD—pancreatic cancer	2.12e-05	0.00027	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—pancreatic cancer	2.11e-05	0.000269	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.1e-05	0.000268	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.07e-05	0.000265	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	2.07e-05	0.000265	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—KRAS—pancreatic cancer	2.07e-05	0.000265	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	2.07e-05	0.000264	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CB—pancreatic cancer	2.06e-05	0.000263	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—pancreatic cancer	2.06e-05	0.000263	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.06e-05	0.000263	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—pancreatic cancer	2.05e-05	0.000262	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—pancreatic cancer	2.04e-05	0.000261	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCG—pancreatic cancer	2.03e-05	0.000259	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	2.02e-05	0.000259	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	1.98e-05	0.000253	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CD—pancreatic cancer	1.98e-05	0.000253	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.96e-05	0.00025	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	1.94e-05	0.000247	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	1.92e-05	0.000245	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—STK11—pancreatic cancer	1.91e-05	0.000244	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	1.9e-05	0.000243	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.89e-05	0.000241	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.87e-05	0.000239	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	1.84e-05	0.000236	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.83e-05	0.000233	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.83e-05	0.000233	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	1.81e-05	0.000231	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.79e-05	0.000229	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTEN—pancreatic cancer	1.78e-05	0.000227	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	1.78e-05	0.000227	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	1.77e-05	0.000226	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	1.76e-05	0.000225	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	1.72e-05	0.00022	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	1.71e-05	0.000219	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	1.7e-05	0.000217	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	1.67e-05	0.000214	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.66e-05	0.000213	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—pancreatic cancer	1.66e-05	0.000212	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	1.66e-05	0.000212	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	1.65e-05	0.000211	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	1.65e-05	0.00021	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.64e-05	0.00021	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	1.64e-05	0.000209	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.61e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	1.6e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	1.6e-05	0.000204	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	1.59e-05	0.000204	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.59e-05	0.000203	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	1.58e-05	0.000202	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.57e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	1.56e-05	0.000199	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	1.54e-05	0.000197	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	1.53e-05	0.000195	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	1.5e-05	0.000191	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	1.49e-05	0.00019	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	1.48e-05	0.000189	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	1.45e-05	0.000186	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTEN—pancreatic cancer	1.45e-05	0.000185	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.44e-05	0.000184	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	1.44e-05	0.000184	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	1.43e-05	0.000182	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	1.42e-05	0.000182	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.4e-05	0.000179	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	1.38e-05	0.000176	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.35e-05	0.000172	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	1.34e-05	0.000172	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.34e-05	0.000171	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOE—pancreatic cancer	1.34e-05	0.000171	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	1.33e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	1.33e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	1.32e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	1.32e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.3e-05	0.000166	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	1.3e-05	0.000166	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	1.29e-05	0.000164	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.26e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	1.26e-05	0.00016	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	1.25e-05	0.00016	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.24e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	1.24e-05	0.000158	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	1.23e-05	0.000158	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	1.22e-05	0.000156	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	1.22e-05	0.000155	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	1.21e-05	0.000155	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	1.21e-05	0.000154	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.21e-05	0.000154	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.18e-05	0.000151	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.16e-05	0.000149	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	1.14e-05	0.000146	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	1.12e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	1.12e-05	0.000143	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.09e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	1.09e-05	0.000139	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	1.08e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	1.08e-05	0.000138	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.06e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.05e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	1.04e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—pancreatic cancer	1.03e-05	0.000131	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	1.02e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	1.02e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	1.01e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	1e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	9.83e-06	0.000126	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	9.72e-06	0.000124	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	9.29e-06	0.000119	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	9.24e-06	0.000118	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	9.19e-06	0.000117	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	9.16e-06	0.000117	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	8.58e-06	0.00011	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	8.53e-06	0.000109	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—pancreatic cancer	8.34e-06	0.000106	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	8.25e-06	0.000105	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTEN—pancreatic cancer	7.98e-06	0.000102	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	7.89e-06	0.000101	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	6.97e-06	8.9e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	5.63e-06	7.2e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—pancreatic cancer	4.6e-06	5.88e-05	CbGpPWpGaD
